Fairchem Organics Limited

NSE:FAIRCHEMOR.NS

1013.15 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 1,649.2831,515.081,476.5341,518.7771,603.4951,515.0771,022.2911,682.5852,249.4171,773.6981,582.7191,676.6171,389.7641,590.9351,068.293948.555350.118891.636801.359
Cost of Revenue 1,359.9071,159.061,069.8511,139.0211,267.6771,104.084815.5151,362.8431,624.7021,436.481,154.4281,155.889900.4091,166.86716.507597.612244.683603.691550.16
Gross Profit 289.376356.02406.683379.756335.818410.993206.776319.742624.715337.218428.291520.728489.355424.075351.786350.943105.435287.945251.199
Gross Profit Ratio 0.1750.2350.2750.250.2090.2710.2020.190.2780.190.2710.3110.3520.2670.3290.370.3010.3230.313
Reseach & Development Expenses 01.6260001.9480001.9390001.539000.4222.5980
General & Administrative Expenses 0174.55200072.21100043.57800067.393004.08234.6190
Selling & Marketing Expenses 02.4280002.5970003.5350001.948006.9141.1520
SG&A 97.456176.9871.77378.05551.64174.80860.6173.20248.65547.11345.06644.21455.14769.34137.9848.93110.99635.77134.89
Other Expenses 2.3622.8132.4524.5511.5231.6882.7190.0332.837-2.840.9130.3654.058-0.1690.0730.1070.006-63.7491.366
Operating Expenses 97.456184.51233.157233.121241.075239.923190.891247.135243.005167.704233.271220.678177.737164.967155.729213.25294.26197.612148.93
Operating Income 191.92171.51175.978151.18694.743359.57318.60472.64381.71169.514195.02300.05311.618277.01196.057137.79813.639211.35102.269
Operating Income Ratio 0.1160.1130.1190.10.0590.2370.0180.0430.170.0960.1230.1790.2240.1740.1840.1450.0390.2370.128
Total Other Income Expenses Net -5.754-11.93-9.66-13.033-12.003-199.995-9.219-16.167-21.221-17.249-14.397-19.864-12.288-36.872-16.014-15.623-17.322-44.357-15.733
Income Before Tax 186.166159.58166.318138.15382.74159.5789.38556.473360.489152.265180.623280.186299.33240.138180.043122.175-3.683166.99386.536
Income Before Tax Ratio 0.1130.1050.1130.0910.0520.1050.0090.0340.160.0860.1140.1670.2150.1510.1690.129-0.0110.1870.108
Income Tax Expense 47.64440.9743.0135.29721.51440.9743.29916.44390.19439.83346.08571.21276.2151.83946.01331.6-1.78536.26621.216
Net Income 138.522117.613123.308102.85661.226118.6046.08640.03270.295112.432134.538208.974223.12188.299134.0390.575-1.898130.72765.32
Net Income Ratio 0.0840.0780.0840.0680.0380.0780.0060.0240.120.0630.0850.1250.1610.1180.1250.095-0.0050.1470.082
EPS 10.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EPS Diluted 10.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EBITDA 217.783187.611199.961172.944117.808172.75880.37393.142403.426187.485214.096318.06332.628277.865212.755154.34127.648200.933119.684
EBITDA Ratio 0.1320.1240.1350.1140.0730.1140.0790.0550.1790.1060.1350.190.2390.1750.1990.1630.0790.2250.149